Skip to main content
Caplight Logo









Oisín Biotechnologies

Oisín Biotechnologies

Private
Seattle, WashingtonHealthcare & Life Scienceshttps://www.oisinbio.com/

Last Round

Grant

Dec 18, 2024

Total Funding Raised

$9.5M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Oisín Biotechnologies is a biotechnology company that develops genetic medicines to address age-related diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

senolytic therapysenescent cell clearancelongevity biotechnologygene therapyage-related diseasesdrug delivery platformanti-aging therapyproteo-lipid vehiclePLVDNA-based therapypreclinical biotechnologysuicide gene therapygenetic medicinesdrug licensingp16 biomarkerprogrammed cell death

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Oisín Biotechnologies Comparables

Compare Oisín Biotechnologies with similar companies based on industry and business-model similarity.

Oisín Biotechnologies comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Deciduous Therapeutics
82%
Rubedo Life Sciences
81%
Numeric Biotech
78%

Oisín Biotechnologies Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantDec 18, 2024
Series AJul 24, 2024
SeedMay 27, 2021
Pre SeedFeb 26, 2020
SeedMar 22, 2017

Key People

Founding team and executive leadership

Eric Garcia

Chief Operating Officer

Executive Team

Oisín Biotechnologies Investors

Notable investors and investment history

Oisín Biotechnologies investors
InvestorRounds
Kizoo Technology CapitalPre Seed
AbbVie VenturesSeries A
AltheaSeed
M-Fund VCPre Seed
SENS Research FoundationPre Seed, Seed
Methuselah FoundationGrant, Pre Seed, Seed
Advani Family OfficePre Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 25, 2026

    Monthly visitors increased 39% MoM, reaching 2.2K.

  • Jan 21, 2026

    Monthly visitors increased 137% MoM.

Oisín Biotechnologies Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Oisín Biotechnologies Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Oisín Biotechnologies's valuation, stock price, and market status.

Firmographic Details

HeadquartersSeattle, Washington
Employee Range17
Year Founded2014
Last FundingDec 18, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?